Company overview
Basic information
Company name
NS Balansas, MB
Company code
306311783
Registered address
Rokiškio r. sav., Rokiškio kaimiškoji sen., Skemų k., Rokiškio g. 6, LT-42101
Registration date
2023-05-10
Company age: 3 y. 4 mo.
Contact information
Edit data
Phone
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Retail sale of pharmaceutical products
Ownership form
Private without foreign capital
MB NS Balansas
Company code: 306311783
Address: Rokiškio r. sav., Rokiškio kaimiškoji sen., Skemų k., Rokiškio g. 6, LT-42101
Download a detailed company report
Make confident decisions with all the information about NS Balansas, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
NS Balansas, MB (company code 306311783) is an operational private small partnership registered on 2023-05-10. It is classified as a micro company in the national private non-financial companies sector and is managed under CEO-only governance. The company is privately owned: Lithuanian natural and legal persons hold more than 50% of the authorised capital, and there is no foreign investor capital. Its registered activity under EVRK G.47.73.00 is Retail sale of pharmaceutical products. The company is based in Skemu k., Rokiškio district municipality, Panevežys County.
Financially, the company remained small but expanded its revenue from EUR 9.2 thousand in 2023 to EUR 31.1 thousand in 2025. Profitability stayed negative, with a net loss of EUR 651 in 2023 and EUR 1.1 thousand in 2025, although the loss margin improved from -7.1% to -3.7%. Equity moved from a negative EUR 651 in 2023 to a positive EUR 97 in 2025. At the end of 2025, liabilities were EUR 65 and total assets were EUR 162.
Financially, the company remained small but expanded its revenue from EUR 9.2 thousand in 2023 to EUR 31.1 thousand in 2025. Profitability stayed negative, with a net loss of EUR 651 in 2023 and EUR 1.1 thousand in 2025, although the loss margin improved from -7.1% to -3.7%. Equity moved from a negative EUR 651 in 2023 to a positive EUR 97 in 2025. At the end of 2025, liabilities were EUR 65 and total assets were EUR 162.